Clinical Trial: Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07147166) titled 'Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy' on July 29.

Brief Summary: The goal of this randomized, prospective, interventional clinical trial is to evaluate the use of Brijjit(R) in reducing the incidence of hypertrophic scarring in individuals undergoing gender-affirming bilateral double incision mastectomies at a single-institution, single-surgeon site (Esther A. Kim, MD). Patients will serve as a self-control (one side of the chest receives intervention, the other serves as a control). Primary endpoints include scar appearance and qualit...